They also found that the treatment of decompensated RV endothelial cells with hydralazine, a DNMT inhibitor, increased miR-126, and that miR-126 upregulation improved RV microcirculation and RV function in a MCT-induced rat model of PAH [41]. Here, DNMT1 is linked to pulmonary arterial hypertension.